Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action
Open Access
- 1 May 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 9 (3) , 193-205
Abstract
Steroid target tissues regulate the local level of steroid hormone that can bind and trans‐activate nuclear receptors (a process known as intracrine modulation). This pre‐receptor regulation can be achieved by hydroxysteroid dehydrogenases (HSDs). For each sex hormone there is a pair of HSD isoforms which act either as reductases or oxidases to convert potent steroid hormones into their cognate inactive metabolites, or vice‐versa. In this manner, HSDs can function as molecular switches to regulate steroid hormone action. Because these HSDs show tissue‐specific expression, inhibitors of these enzymes are predicted to cause tissue‐specific responses to steroid hormones. These inhibitors would represent a new class of therapeutics called ‘selective intracrine modulators’ (SIMs). SIMs are expected to have the same tissue‐specific effects as selective steroid receptor modulators but a different mode of action as their effects are enzyme‐ and not receptor‐mediated. HSDs responsible for these interconversions belong to two protein superfamilies: the short‐chain dehydrogenases/reductases; and the aldo‐keto reductases. Crystal structures exist for HSDs in both families, making rational design of SIMs a reality. Broad‐based criteria have been established which must be fulfilled to validate each HSD isoform as a potential SIM target.Keywords
This publication has 69 references indexed in Scilit:
- Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolismThe Prostate, 2003
- Further Characterization of Human Microsomal 3α-Hydroxysteroid DehydrogenaseArchives of Biochemistry and Biophysics, 2001
- The effects of SERMs on the skeletonJournal of Endocrinological Investigation, 1999
- Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17β-hydroxysteroid dehydrogenase type 1International Journal of Cancer, 1996
- Molecular Cloning of Human Type 3 3α-Hydroxysteroid Dehydrogenase That Differs from 20α-Hydroxysteroid Dehydrogenase by Seven Amino AcidsBiochemical and Biophysical Research Communications, 1996
- 11β-Hydroxysteroid dehydrogenase activity and corticosteroid hormone actionSteroids, 1994
- Identification and characterization of cytosolic sulfotransferase activities in MCF-7 human breast carcinoma cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Tyr-179 and Lys-183 are essential for enzymatic activity of 11β-hydroxysteroid dehydrogenaseBiochemical and Biophysical Research Communications, 1992
- Complete amino acid sequence of human placental 17β‐hydroxysteroid dehydrogenase deduced from cDNAFEBS Letters, 1988
- Characterization of the 3α-hydroxysteroid dehydrogenase of dog prostateThe Journal of Steroid Biochemistry and Molecular Biology, 1977